Dr. Lee is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3333 Burnet Ave
MLC 7018
Cincinnati, OH 45229Phone+1 513-803-8377- Is this information wrong?
Education & Training
- Cincinnati Children's Hospital Medical CenterFellowship, Pediatric Hematology/Oncology, 2013 - 2016
- Cincinnati Children's Hospital Medical CenterResidency, Pediatrics, 2010 - 2013
- Emory University School of MedicineClass of 2010
Certifications & Licensure
- OH State Medical License 2010 - 2024
- KY State Medical License 2021 - 2022
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- 18 citationsTRAF6 functions as a tumor suppressor in myeloid malignancies by directly targeting MYC oncogenic activity.Tomoya Muto, Maria Guillamot, Jennifer Yeung, Jing Fang, Joshua Bennett, Bettina Nadorp, Audrey Lasry, Luna Zea Redondo, Kwangmin Choi, Yixiao Gong, Callum S Walker, K...> ;Cell Stem Cell. 2022 Feb 3
- 3 citationsTreatment of posttransplant lymphoproliferative disorder with poor prognostic features in children and young adults: Short-course EPOCH regimens are safe and effectiveJeremy D. Rubinstein, Rachana Shah, Erin H. Breese, Karen Burns, Jennifer Mangino, Robin E. Norris, Lynn Lee, Benjamin Mizukawa, Maureen M. O'Brien, Christine L Philli...> ;Pediatric Blood & Cancer. 2021 May 21
- 8 citationsLAMP-5 is an essential inflammatory-signaling regulator and novel immunotherapy target for Mixed Lineage Leukemia-Rearranged acute leukemia.Gabriel Gracia-Maldonado, Jason Clark, Matthew Burwinkel, Brenay Greenslade, Mark Wunderlich, Nathan Salomonis, Dario Leone, Evelina Gatti, Philippe Pierre, Ashish R K...> ;Haematologica. 2021 Apr 29
- Join now to see all
Abstracts/Posters
- Innate Immune Signaling Suppresses Acute Leukemia By Modifying MYC Oncogenic ActivityLynn Lee, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- V2 Trial: A Phase I Study of Venetoclax Combined with CPX-351 for Children, Adolescents and Young Adults with Relapsed or Refractory Acute LeukemiaLynn Lee, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Hospital Affiliations
- Cincinnati Children's Hospital Medical CenterCincinnati, Ohio
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: